Academic history

Adam Sperling, MD, PhD, received his medical degree and PhD at the University of California, Los Angeles, CA in 2011, and completed his residency in internal medicine at the Brigham and Women’s Hospital in Boston, MA. Dr Sperling then completed his fellowship in Hematology and Oncology at the Dana-Farber Cancer Institute, and joined the Dana-Farber Cancer Institute in 2018.

Speaking on clonal hematopoiesis and disease progression

Dr Sperling’s research focuses on understanding the mechanisms of disease evolution in hematologic malignancies, clonal hematopoiesis, and the development of drug resistance in multiple myeloma.